Risk-benefit analysis of nucleic acid testing: the French experience

Biologicals. 1999 Dec;27(4):343-8. doi: 10.1006/biol.1999.0230.
No abstract available

MeSH terms

  • Blood Donors
  • Blood Transfusion*
  • Cost-Benefit Analysis
  • France
  • HIV / isolation & purification
  • Hepacivirus / isolation & purification*
  • Hepatitis B virus / isolation & purification
  • Humans
  • Plasma / virology
  • RNA, Viral / blood*
  • Risk Factors
  • Transfusion Reaction

Substances

  • RNA, Viral